Published 2020 | Version v1

Publication Metadata-only

Comment on: Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

Creators: Del Puente, Filippo; Berruti, Marco; Riccardi, Niccolò; di Biagio, Antonio

Others:: Del Puente, Filippo; Berruti, Marco; Riccardi, Niccolò; di Biagio, Antonio

Additional details

Created:: April 14, 2023
Modified:: November 29, 2023